Anti-oxidative capacity in patients with ataxia telangiectasia

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 535-539

  Reichenbach, J ^b   Schubert, R ^b   Schwan, C ^a   Muller K ^a   Bohles H J ^a   Zielen, S ^b,c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Ataxia telangiectasia; Oxidative stress; TEAC; Vitamins

Indexed keywords

REACTIVE OXYGEN METABOLITE; UBIDECARENONE;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION RESISTANCE; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANTIGENS, CD45; ANTIOXIDANTS; ATAXIA TELANGIECTASIA; CHILD; CHILD, PRESCHOOL; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; UBIQUINONE; VITAMIN A; VITAMIN E;

EID: 0000437602     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01000.x     Document Type: Article

References (36)

1. 1 Meyn MN. Ataxia telangiectasia and cellular responses to DNA damage. Cancer Res 1995; 55:5591-6001.
2. 2 Duchaud E, Ridet A, Stoppa-Lyonnet D, Janin N, Moustacchi E, Rosselli F. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res 1996; 56:1400-4.
3. 3 Rotman G, Shiloh Y. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defense against oxidative stress. Cancer Surv 1997; 29:285-304.
4. 4 Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119:598-620.
5. 5 Baier-Bitterlich G, Fuchs D, Wachter H. Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem Pharmacol 1997; 53:755-63.
6. 6 Cerutti P. Oxy-radicals and cancer. Lancet 1994; 344:862-3.
7. 7 Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during HIV-1 infection. Arch Intern Med 1993; 153:2149-54.
8. 8 Pacht E, Diaz P, Clanton T, Hart J, Gadek J. Serum vitamin E decreases in HIV-seropositive subjects over time. J Lab Clin Med 1997; 130:293-6.
9. 9 Omene JA, Easington CR, Glew RH, Prosper M, Ledlie S. Serum beta-carotene deficiency in HIV-infected children. J Natl Med Assoc 1996; 88:789-93.
10. 10 Leke L, Saygili A, Vural M, Risbourg B. Malnutrition and immunodeficiency in children. Arch Pediatr 1996; 3:705-13.
11. 11 Gogos CA, Ginopoulus P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodefieiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998; 82:395-402.
12. 12 Bell SJ, Chavali S, Bistrian BR, Conolly CA, Utsunomiya T, Forse RA. Dietary fish oil and cytokine and eicosanoid production during human immunodeficiency virus infection. J Parenter Enteral Nutr 1996; 20:43-9.
13. 13 Saxon A, Keld B, Braun J, Dotson A, Sidell N. Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display, and in vitro and in vivo B-cell antibody production. Immunology 1993; 80:477-87.
14. 14 Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol 1997; 40:166-96.
15. 15 Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84:407-12.
16. 16 Whitburn KD, Shieh Sellers RM, Hoffmann MZ. Redox transformations in ferrimyoglobin induced by radiation-generated free radicals in aqueous solution. J Biol Chem 1982; 257:1860-9.
17. 17 Vuilleumier JP, Keller HE, Gysel D, Hunzicker F. Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part 1: the fat soluble vitamins A and E, and beta-carotene. Int J Vitam Nutr Res 1983; 53:265-72.
18. 18 Grossi G, Bargossi AM, Fiorella PL, Piazzi S, Battino M, Bianchi GF. Improved high-performance liquid chromatographic method for the determination of coenzyme Q10 in plasma. J Chromatogr 1992; 593:217-26,
19. 19 Tang A, Graham NMH, Semba RD, Saah AJ. Association between vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11:613-20.
20. 20 Piedimonte G, Guetard D, Magnani M, et al. Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus. J Inf Dis 1997; 176:655-64.
21. 21 Aukrust P, Berge RK, Muller F, Ueland PM, Svardal AM, Froland SS. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency - a marker of enhanced oxidative stress. Eur J Clin Invest 1997; 27:723-30.
22. 22 Schubert R, Kappenhagen N, Royer N, Bühring I, Zielen S. Lymphocytes in patients with Ataxia Telangiectasia constantly undergo apoptosis. Dis Markers 1998; 14:66-7.
23. 23 Paganelli R, Scala E, Scarselli E et al. Selective deficiency of CD4+/ CD45+ lymphocytes in patients with ataxia telangiectasia. J Clin Immunol 1992; 12:84-91.
24. 24 Shiloh Y, Rotman G. Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints. J Clin Immunol 1996; 16:254-9.
25. 25 Meydani M. Vitamin E. Lancet 1995; 345:170-5.
26. 26 Harding AE, Muller DPR, Thomas PK, Willison HJ. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann Neurol 1982; 12:419-24.
27. 27 Sokol RJ, Kayden HJ, Bettis DB, Traber MG, Neville H, Ringel S. Isolated vitamin E deficiency in the absence of fat malabsorption-familial and sporadic cases: characterization and investigation of causes. J Lab Clin Med 1988; 111:548-59.
28. 28 Battisti C, Formichi P, Federico A. Vitamin E serum levels are normal in ataxia telangiectasia (Louis-Bar disease). J Neurol Sci 1996; 141:114-6.
29. 29 Amromin GD, Boder E, Teplitz R. Ataxia telangiectasia with a 32 year survival. A clinicopathological report. J Neuropathol Exp Neurol 1979; 138:621-43.
30. 30 Haendeler J, Zeiher A, Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. E J Pharmacol 1996; 317:407-11.
31. 31 Barroso MP, Gómez-Díaz C, López-Lluch G, Malagón MM, Crane FL, Navas P. Ascorbate and α-tocopherol prevent apoptosis induced by serum removal independent of Bcl-2. Arch Biochem Biophys 1997; 343:243-8.
32. 32 Iwata M, Mukai M, Nakai Y, Iseki R. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J Immunol 1992; 149:3302-8.
33. 33 Bates CJ. Vitamin A. Lancet 1995; 345:31-5.
34. 34 Allende LM, Corell A, Madrono A et al. Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology 1997; 90:388-96.
35. 35 Semba RD, Muhilal Ward BJ et al. Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet 1993; 341:5-8.
36. 36 Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15:177-202.